Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.
about
Human primary lung endothelial cells in culturePulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series.Erythropoietin upregulation in pulmonary arterial hypertensionBone marrow-derived vascular modulatory cells in pulmonary arterial hypertension.Coenzyme Q supplementation in pulmonary arterial hypertension.Imatinib in pulmonary arterial hypertension: c-Kit inhibitionThe crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms.Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.Epigenetic mechanisms of pulmonary hypertension.Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension.Flow Cytometric Quantification of Peripheral Blood Cell β-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial HypertensionPulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertensionThe role of redox signaling in epigenetics and cardiovascular disease.Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.Versican accumulates in vascular lesions in pulmonary arterial hypertension.miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation.Involvement of endothelial progenitor cells in the formation of plexiform lesions in broiler chickens: possible role of local immune/inflammatory response.Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia.Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.Relevant issues in the pathology and pathobiology of pulmonary hypertension.Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulationVascular repair and regeneration as a therapeutic target for pulmonary arterial hypertensionAnticipated classes of new medications and molecular targets for pulmonary arterial hypertensionOrigin and production of inflammatory perivascular macrophages in pulmonary hypertension.Hematological disorders and pulmonary hypertension.Discovery of a murine model of clinical PAH: Mission impossible?Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in FibrosisHIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstrictionAssociation of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.Pulmonary arterial hypertension in a patient with Cowden syndrome and the PTEN mutation.Myeloid Targets for Pulmonary Arterial Hypertension: Time for Another Look.The Role of Bone Marrow-derived Cells in Pulmonary Arterial Hypertension. What Lies Beneath?Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension.Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.
P2860
Q30517752-4ECC3498-76B1-4812-8861-185FD92A6230Q33738626-B3AFF74C-B9A0-4231-B5D7-16BCDC77FB78Q33805982-46E87911-FD7D-4A0F-BA41-B4A56C950B8AQ33806247-E7F4D4CF-BF58-4449-90B5-C5DA9FC30241Q34085977-91E525F4-5B98-4D82-BBA7-EFD6B47FA863Q34782487-CEE90374-7E01-45C3-8C34-C30BA5AC5F54Q34924892-0C215FEF-6190-4258-9FCA-A140056AA038Q35115789-A310BAB3-62C1-46D5-9975-666F2157C195Q35168107-54A32BF6-88C0-4C0A-B0E4-6E2D1FF10459Q35225879-AB7F2DA6-2317-4323-B199-C362FD65D382Q35346528-1F855FB3-340D-4721-B8B3-6B5CCA5E608AQ35573935-79AB03B9-115A-4D98-A5D8-334230F72E62Q35695350-57500D4E-734C-41B0-B0A0-7DE9B7643685Q35896204-977D1001-F87B-4CA8-8495-C5BC50144364Q36043165-3A6BB2F1-B56F-4168-8162-4C121B838D84Q36163044-45EA59AF-A6C8-4F69-826A-611D90E7766BQ36761147-19E949C1-9BD9-43EF-B217-BC4DF260B0B3Q36847595-A7A0BFBB-5B30-413A-9D01-AC087FB617A7Q37004101-6CC7444E-ADD1-44CB-A4A3-2D9B06E645DAQ37248333-D2CE786A-6C3A-452E-9BC1-2B79BD51D62DQ37556377-4B5BDBB1-D789-4CCC-BE48-C755B24DA6B5Q37602849-5B05828C-A76D-4A41-ADD7-52CB35BA083CQ37638919-D5DF1A84-4C0A-42A9-95B9-9DDCDDC5BB6BQ37651790-20629F69-3F37-40C0-A760-72911FB49381Q37673917-5F3BA1EF-2942-4D49-986E-989953C771ABQ37907120-D18877EB-7382-4931-BC4B-88F6D70EFDD4Q38099709-26414569-A009-41ED-8E62-934BDA24C2DBQ38105550-8505112A-274E-4750-8951-97872954E7E7Q38601788-1CC0C77A-D634-4B33-8293-132DB890ADC4Q39077582-5C7AB3E1-2DD3-4D50-BFE7-A983812C5D9DQ39089351-4ABFFF17-38F7-4E3C-A219-ED9162D8ED6CQ39370856-93B65A1B-F92A-4E32-9F7C-E810A9DAD93AQ40390084-4B67D756-5BF2-4EFD-BABC-EE269CC151CFQ40896042-DBC013AF-0902-4AA1-9171-E22F06C0177BQ41811507-FCDAF201-9050-487B-A86C-E8C117BE6FF2Q41898056-735DEFAF-C703-487F-8FBB-6436025264D8Q42850735-4BE41230-A5D3-4A85-8100-F977AEDCE06CQ45970134-33287B7C-E173-4380-AB27-B7D43FD1ED02Q46280894-E4B7BB7C-AC27-4C64-81F0-92E961EC0EA2Q47671148-B075A931-2C48-4B2E-92B1-3AAF4233720F
P2860
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@ast
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@en
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@nl
type
label
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@ast
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@en
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@nl
prefLabel
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@ast
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@en
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@nl
P2093
P2860
P1433
P1476
Hypoxia-inducible factors in h ...... trinsic myeloid abnormalities.
@en
P2093
Alan Lichtin
Deepa George
Jacqueline Sharp
James E Loyd
Karl Theil
Kewal Asosingh
Margaret Park
Raymond Tubbs
Samar Farha
P2860
P304
P356
10.1182/BLOOD-2010-09-306357
P407
P577
2011-01-21T00:00:00Z